SMARCA2 and leukemia: The BAF complex, driven by BRG1 (SMARCA4) or BRM (SMARCA2), enables transcription factors such as PU.1 and MYC to bind enhancers and promoters, sustaining oncogenic transcriptional programs essential for leukemia cell survival.